IDH1 and glioma: Voss et al. also found that new contrast-enhancing spots (NCEs) were common in young patients with IDH-mutated gliomas after radiotherapy [41], which may be related to the vascular lesions, hypoxia, and tissue necrosis caused by radiotherapy [42].